UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer

PloS one, 2020-11, Vol.15 (11), p.e0242544-e0242544

2020

Link zum Volltext

Verfügbarkeit prüfen

Returning to work in lung cancer survivors—a multi-center cross-sectional study in Germany

Supportive care in cancer, 2021-07, Vol.29 (7), p.3753-3765

2021

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience

Annals of hematology, 2023-05, Vol.102 (5), p.1045-1052

2023

Link zum Volltext

Verfügbarkeit prüfen

Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012-2018

BMC pulmonary medicine, 2023-01, Vol.23 (1), p.16-16, Article 16

2023

Link zum Volltext

Verfügbarkeit prüfen

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer

Frontiers in oncology, 2023-09, Vol.13, p.1273478-1273478

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221097191-17588359221097191

2022

Link zum Volltext

Verfügbarkeit prüfen

Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia

Leukemia, 2022-10, Vol.36 (10), p.2396-2407

2022

Link zum Volltext

Verfügbarkeit prüfen

Early‐onset venous thromboembolisms in newly diagnosed non‐promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy

European journal of haematology, 2023-04, Vol.110 (4), p.426-434

2023

Link zum Volltext

Verfügbarkeit prüfen

Intracranial hemorrhage in newly diagnosed non‐promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy

European journal of haematology, 2022-02, Vol.108 (2), p.125-132

2022

Link zum Volltext

Verfügbarkeit prüfen

Correction: Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia

Leukemia, 2022-12, Vol.36 (12), p.2950-2950

2022

Link zum Volltext

Verfügbarkeit prüfen

Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirations

Annals of hematology, 2022-08, Vol.101 (8), p.1703-1710

2022

Link zum Volltext

Verfügbarkeit prüfen

Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting

Journal of cancer research and clinical oncology, 2023-09, Vol.149 (11), p.9243-9252

2023

Link zum Volltext

Verfügbarkeit prüfen

Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma

Journal of cancer research and clinical oncology, 2022-06, Vol.148 (6), p.1465-1472

2022

Link zum Volltext

Verfügbarkeit prüfen

Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers

Lung cancer (Auckland), 2019-07, Vol.10, p.67-80

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer

Journal of cancer research and clinical oncology, 2018-12, Vol.144 (12), p.2457-2463

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma

Annals of hematology, 2019-03, Vol.98 (3), p.647-656

2019

Link zum Volltext

Verfügbarkeit prüfen

Translatome Proteomics Identifies Autophagy As a Resistance Mechanism to on-Target FLT3 Inhibitors in Acute Myeloid Leukemia

Blood, 2022-11, Vol.140 (Supplement 1), p.3100-3100

2022

Link zum Volltext

Verfügbarkeit prüfen

Kapitel 13 - Niere und Elektrolyte, Osteoprotektion

Therapie-Handbuch Onkologie und Hämatologie, 2022, p.92-99

Stratmann, Jan A.

2022

Link zum Volltext

Verfügbarkeit prüfen

Kapitel 34 - Pleuramesotheliom

Therapie-Handbuch Onkologie und Hämatologie, 2022, p.247-250

Stratmann, Jan A.

2022

Link zum Volltext

Verfügbarkeit prüfen

Kapitel 14 - Pleuramesotheliom

Therapie-Handbuch - Pneumologie, 2022, p.123-126

Stratmann, Jan A.

2022

Link zum Volltext

Verfügbarkeit prüfen

Kapitel 11 - Gerinnung

Therapie-Handbuch Onkologie und Hämatologie, 2022, p.77-83

2022

Link zum Volltext

Verfügbarkeit prüfen

Titelblatt

Therapie-Handbuch - Pneumologie, 2022, p.III-III

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(86)
Deutsch
(16)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer

Returning to work in lung cancer survivors—a multi-center cross-sectional study in Germany

Diagnostic yield, indications, and outcomes of cranial imaging in AML patients admitted for intensive induction or consolidation chemotherapy: a single-center experience

Evolution of treatment patterns and survival outcomes in patients with advanced non-small cell lung cancer treated at Frankfurt University Hospital in 2012-2018

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer

Clinical predictors of survival in patients with relapsed/refractory small-cell lung cancer treated with checkpoint inhibitors: a German multicentric real-world analysis

Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia

Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations

Early‐onset venous thromboembolisms in newly diagnosed non‐promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy

Intracranial hemorrhage in newly diagnosed non‐promyelocytic acute myeloid leukemia patients admitted for intensive induction chemotherapy

Correction: Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia

Sotorasib in KRAS G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in Germany

Relapse surveillance of acute myeloid leukemia patients in first remission after consolidation chemotherapy: diagnostic value of regular bone marrow aspirations

Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting

Colonization with multidrug-resistant organisms impairs survival in patients with hepatocellular carcinoma

Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers

Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer

Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma

Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer

Translatome Proteomics Identifies Autophagy As a Resistance Mechanism to on-Target FLT3 Inhibitors in Acute Myeloid Leukemia

Kapitel 13 - Niere und Elektrolyte, Osteoprotektion

Kapitel 34 - Pleuramesotheliom

Kapitel 14 - Pleuramesotheliom

Kapitel 11 - Gerinnung

Titelblatt

Suchergebnisse filtern